Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children
Agustin Calatroni, James E. Gern, Kimberly A. Dill‐McFarland, Daniel J. Jackson et al.
Citations
10 citations
Journal
JAMA Pediatrics
Topics
Asthma and respiratory diseases
Field-Weighted Citation Impact (FWCI)
11.64
article
Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children
Agustin Calatroni, James E. Gern, Kimberly A. Dill‐McFarland, Daniel J. Jackson, Gurjit K. Khurana Hershey, Ryan C. Murphy, Edward M. Zoratti, Susan V. Lynch, William W. Busse, Matthew C. Altman, Meyer Kattan, Rebecca S. Gruchalla, Leonard B. Bacharier, George T. O’Connor, Alkis Togias, Stephen J. Teach, Jeffrey R. Stokes, Naresh Doni Jayavelu, Patrice M. Becker, Rajesh Kumar, Michael G. Sherenian, Rachel G. Robison, Tomasz Janczyk, Andrew H. Liu, Michelle A. Gill
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA PediatricsVol. 179(9)
Institutions
Cincinnati Children's Hospital Medical Center (US), Lurie Children's Hospital (US), National Institutes of Health (US), Children's National (US), University of Wisconsin–Madison (US), Henry Ford Health System (US), University of California, San Francisco (US), University of Washington (US), Washington University in St. Louis (US), Institute for Systems Biology (US), Children's Hospital Colorado (US), Monroe Carell Jr. Children's Hospital (US), National Institute of Allergy and Infectious Diseases (US), Rho (United States) (US), Columbia University (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)